Back to Journals » Hepatic Medicine: Evidence and Research » Volume 10 » Comparison of extracorporeal cellular therapy (ELAD®) vs standard of care in a randomized controlled clinical trial in treating Chinese subjects with acute-on-chronic liver failure
Please verify you are not a robot.